Literature DB >> 24721673

Proteomic profiling reveals that EhPC4 transcription factor induces cell migration through up-regulation of the 16-kDa actin-binding protein EhABP16 in Entamoeba histolytica.

Olga Hernández de la Cruz1, Marcos Muñiz-Lino1, Nancy Guillén2, Christian Weber2, Laurence A Marchat3, Itzel López-Rosas1, Erika Ruíz-García4, Horacio Astudillo-de la Vega5, Lizeth Fuentes-Mera6, Elizbeth Álvarez-Sánchez1, Guillermo Mendoza-Hernández7, César López-Camarillo8.   

Abstract

Actin cytoskeleton is an essential structure involved in cell migration and invasion in parasites. In Entamoeba histolytica, the protozoan parasite causing human amoebiasis, the mechanisms underlying the expression of migration-related genes are poorly understood. Here, we investigated the biological effects of ectopic overexpression of EhPC4 (positive coactivator 4) in cell migration of E. histolytica trophozoites. Using differential in gel two-dimensional electrophoresis, 33 modulated proteins were detected in EhPC4-overexpressing cells. By electrospray ionization tandem mass spectrometry (ESI-MS/MS) analysis, 16 of these proteins were identified. Interestingly, four up-regulated proteins involved in cytoskeleton organization and cell migration were identified. Particularly, we found the up-regulation of a 16-kDa actin-binding protein (EhABP16) which is a putative member of the cofilin/tropomyosin family involved in actin polymerization. EhPC4 overexpression induced a significant increase in migration of trophozoites and in the destruction of human SW480 colon cells. Consistently, silencing of gene expression by RNA interference of EhABP16 significantly impairs cell migration. These changes were associated to alterations in the organization of actin cytoskeleton, and suppression of uropod-like structure formation in EhABP16-deficient cells. In summary, we have uncovered novel proteins modulated by EhPC4, including EhABP16, with a potential role in cell migration, cytopathogenicity and virulence in E. histolytica. BIOLOGICAL SIGNIFICANCE: The human pathogen Entamoeba histolytica infects around 50million people worldwide resulting in 40,000-100,000 deaths annually. Cell motility is a complex trait that is critical for parasites adaptation, spread and invasion processes into host tissues; it has been associated with virulence. In this study, we used a differential proteomic approach to demonstrate that E. histolytica EhPC4 induces changes in the expression of actin cytoskeleton proteins, including EhABP16, promoting a significant increase in cell motility and destruction of intestinal human cells. Particularly, we demonstrated for the first time that abrogation of EhABP16 impairs cell migration by altering the actin cytoskeleton dynamics and uropod-like structure formation in trophozoites. These data contribute to the understanding of molecular mechanisms that regulate virulence properties in this neglected protozoan parasite.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Amoebiasis; Cell migration; EhABP16; EhPC4; Entamoeba histolytica; SW480 monolayers destruction

Mesh:

Substances:

Year:  2014        PMID: 24721673     DOI: 10.1016/j.jprot.2014.03.041

Source DB:  PubMed          Journal:  J Proteomics        ISSN: 1874-3919            Impact factor:   4.044


  14 in total

1.  Silencing the cleavage factor CFIm25 as a new strategy to control Entamoeba histolytica parasite.

Authors:  Juan David Ospina-Villa; Nancy Guillén; Cesar Lopez-Camarillo; Jacqueline Soto-Sanchez; Esther Ramirez-Moreno; Raul Garcia-Vazquez; Carlos A Castañon-Sanchez; Abigail Betanzos; Laurence A Marchat
Journal:  J Microbiol       Date:  2017-09-28       Impact factor: 3.422

2.  A biochemical and biophysical model of G-quadruplex DNA recognition by positive coactivator of transcription 4.

Authors:  Wezley C Griffin; Jun Gao; Alicia K Byrd; Shubeena Chib; Kevin D Raney
Journal:  J Biol Chem       Date:  2017-04-17       Impact factor: 5.157

Review 3.  Entamoeba stage conversion: progress and new insights.

Authors:  Dipak Manna; Gretchen M Ehrenkaufer; Daniela Lozano-Amado; Upinder Singh
Journal:  Curr Opin Microbiol       Date:  2020-10-06       Impact factor: 7.934

Review 4.  Target acquired: transcriptional regulators as drug targets for protozoan parasites.

Authors:  H A Walters; L A Temesvari
Journal:  Int J Parasitol       Date:  2021-03-13       Impact factor: 4.330

Review 5.  Recent advances in Entamoeba biology: RNA interference, drug discovery, and gut microbiome.

Authors:  Pedro Morgado; Dipak Manna; Upinder Singh
Journal:  F1000Res       Date:  2016-10-26

Review 6.  "Omic" investigations of protozoa and worms for a deeper understanding of the human gut "parasitome".

Authors:  Valeria Marzano; Livia Mancinelli; Giorgia Bracaglia; Federica Del Chierico; Pamela Vernocchi; Francesco Di Girolamo; Stefano Garrone; Hyppolite Tchidjou Kuekou; Patrizia D'Argenio; Bruno Dallapiccola; Andrea Urbani; Lorenza Putignani
Journal:  PLoS Negl Trop Dis       Date:  2017-11-02

7.  In Entamoeba histolytica, a BspA family protein is required for chemotaxis toward tumour necrosis factor.

Authors:  Anne Silvestre; Aurélie Plaze; Patricia Berthon; Roman Thibeaux; Nancy Guillen; Elisabeth Labruyère
Journal:  Microb Cell       Date:  2015-07-06

8.  Proteomic Study of Entamoeba histolytica Trophozoites, Cysts, and Cyst-Like Structures.

Authors:  Milka Luna-Nácar; José Navarrete-Perea; Bárbara Moguel; Raúl J Bobes; Juan P Laclette; Julio C Carrero
Journal:  PLoS One       Date:  2016-05-26       Impact factor: 3.240

9.  The Entamoeba histolytica, Arp2/3 Complex Is Recruited to Phagocytic Cups through an Atypical Kinase EhAK1.

Authors:  Mrigya Babuta; M Shahid Mansuri; Sudha Bhattacharya; Alok Bhattacharya
Journal:  PLoS Pathog       Date:  2015-12-08       Impact factor: 6.823

10.  Multinucleation and Polykaryon Formation is Promoted by the EhPC4 Transcription Factor in Entamoeba histolytica.

Authors:  Olga Hernández de la Cruz; Laurence A Marchat; Nancy Guillén; Christian Weber; Itzel López Rosas; José Díaz-Chávez; Luis Herrera; Arturo Rojo-Domínguez; Esther Orozco; César López-Camarillo
Journal:  Sci Rep       Date:  2016-01-21       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.